UNCX activators form a class of chemicals primarily aiming to indirectly enhance or support the transcriptional activity of the UNCX homeobox gene. Given UNCX's roles in somitogenesis, neurogenesis, and neuro-hormonal connections, it's clear that its precise regulation is paramount. Retinoic Acid, for instance, is instrumental in the anterior-posterior patterning of somites, thereby offering a developmental milieu conducive for UNCX's function. In parallel, chemicals such as Valproic Acid and Sodium Butyrate, both HDAC, are recognized for their ability to augment gene transcription, creating an environment where genes interrelated with UNCX pathways can thrive.
cAMP and its analog, 8-Br-cAMP, are involved in numerous signaling pathways, and by setting certain cellular states, they can bolster processes tied to UNCX-driven neurogenesis. Trichostatin A, an HDAC like Valproic Acid, has to back transcriptional activities interlinked with UNCX. Chemicals like Dorsomorphin, which inhibit BMP, or Pifithrin-α, which modulates p53-mediated transcription, further exemplify the intricacy of cellular biochemistry in relation to UNCX. They demonstrate that even though their primary targets might be distinct, the cellular ripple effect can touch upon the pathways and processes where UNCX operates. The indirect modulatory of these chemicals underscores the interdependence of cellular processes and highlights the need for a holistic view when considering the modulation of a specific protein like UNCX.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid governs the anterior-posterior patterning of somites. It can indirectly promote UNCX activity by establishing the necessary developmental context in which UNCX operates. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP is integral to various signaling pathways and can, in specific cellular conditions, bolster UNCX-related neurogenic processes. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As an HDAC inhibitor, Valproic Acid enhances gene transcription, potentially supporting genes in pathways intertwined with UNCX activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
This HDAC inhibitor can indirectly boost transcriptional processes related to UNCX, possibly aiding in its cellular functions. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Analog of cAMP that can promote cellular pathways related to UNCX-mediated neurogenesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another HDAC inhibitor that can potentially support transcriptional activities linked to UNCX. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
BMP inhibitor that can regulate somitogenesis, thereby influencing the context in which UNCX functions. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
A protein synthesis inhibitor which, under certain circumstances, might influence transcriptional regulation related to UNCX. | ||||||
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
By modulating p53-mediated transcription, Pifithrin-α(HBr) can potentially set the stage for indirect modulation of UNCX activity. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
DNA methyltransferase inhibitor that might support transcriptional activities intertwined with UNCX. | ||||||